HALO
Halozyme Therapeutics, Inc. (HALO)
Last Price$61.4(0.0%)
Market Cap$7,773.1M
1Y Forward Revenue growth
18.6%
1Y Forward EPS growth
22.6%
Last EPS & EPS Surprise
$1.08
6.8% miss
Last 10 Earnings
3 Beat / 7 Miss

HALO Revenue and EPS Expectations

Annual
Quarterly

Revenue

Dec'22Dec'23Dec'24Dec'25Dec'26Dec'27Dec'28Dec'29$660.1M$829.3M$1,015.3M$1,189.8M$1,471.4M$1,721.4M$1,848.7M$1,735.3M
Revenue actual
Revenue estimate

EPS

Dec'22Dec'23Dec'24Dec'25Dec'26Dec'27Dec'28Dec'29$1.48$2.13$3.50$5.06$6.73$8.50$9.33$8.36
EPS actual
EPS estimate
Dec'22Dec'23Dec'24Dec'25Dec'26Dec'27Dec'28Dec'29
Revenue growth48.9%25.6%22.4%18.6%23.7%17.0%7.4%(6.1%)
EPS growth(48.3%)43.9%64.3%22.6%33.0%26.2%9.8%(10.4%)

HALO Earnings Surprises

Crunching data... Almost there!

HALO Earnings History

Mar'15Jun'15Sep'15Dec'15Mar'16Jun'16Sep'16Dec'16Mar'17Jun'17Sep'17Dec'17Mar'18Jun'18Sep'18Dec'18Mar'19Jun'19Sep'19Dec'19Mar'20Jun'20Sep'20Dec'20Mar'21Jun'21Sep'21Dec'21Mar'22Jun'22Sep'22Dec'22Mar'23Jun'23Sep'23Dec'23Mar'24Jun'24Sep'24Dec'24
Revenue actual$18.7M$43.4M$20.8M$52.2M$42.5M$33.3M$31.9M$39.0M$29.6M$33.8M$63.7M$189.6M$30.9M$35.2M$25.6M$60.2M$56.9M$39.1M$46.2M$53.7M$25.4M$55.2M$65.3M$121.7M$89.0M$136.5M$115.8M$102.0M$117.3M$152.4M$209.0M$181.5M$162.1M$221.0M$216.0M$230.0M$195.9M$231.4M$290.1M$298.0M
Revenue estimate$20.3M$20.3M$20.3M$20.3M$53.1M$53.1M$53.1M$53.1M$28.5M$28.5M$28.5M$28.5M$35.8M$35.8M$35.8M$35.8M$67.8M$42.8M$55.0M$56.9M$43.0M$66.7M$59.9M$120.0M$84.9M$104.1M$105.8M$101.5M$128.3M$138.6M$191.2M$192.1M$179.3M$200.0M$216.1M$231.0M$199.7M$204.9M$252.2M$285.7M
Revenue surprise7.9%114.2%2.6%157.8%20.0%37.2%40.0%26.6%3.9%18.6%123.9%566.0%13.7%1.6%28.6%68.3%16.0%8.5%15.9%5.7%41.0%17.2%9.0%1.4%4.9%31.1%9.4%0.5%8.6%9.9%9.3%5.5%9.6%10.5%0.0%0.4%1.9%12.9%15.0%4.3%
EPS actual($0.12)$0.02($0.19)$0.03($0.16)($0.21)($0.23)($0.22)($0.26)($0.23)$0.02$0.87($0.19)($0.16)($0.19)($0.02)$0.01($0.10)($0.17)($0.24)($0.04)$0.19$0.27$0.54$0.20$0.64$1.53$0.48$0.44$0.16$0.45$0.43$0.29$0.57$0.62$0.66$0.61$0.73$1.08$1.08
EPS estimate($0.14)($0.14)($0.14)($0.14)($0.24)($0.24)($0.24)($0.24)($0.24)($0.24)($0.24)($0.24)($0.25)($0.25)($0.25)($0.25)$0.01($0.14)($0.12)($0.18)($0.02)$0.25$0.19$0.53$0.32$0.43$0.42$0.38$0.46$0.47$0.36$0.30$0.38$0.63$0.71$0.83$0.69$0.76$0.99$1.16
EPS surprise14.3%114.3%35.7%121.4%33.3%12.5%4.2%8.3%8.3%4.2%108.3%462.5%24.0%36.0%24.0%93.9%27.9%29.2%40.0%31.8%114.3%22.8%38.6%2.1%37.1%47.2%261.3%24.8%4.6%66.0%24.4%43.9%24.2%9.5%12.2%20.0%11.1%3.8%9.0%6.8%

FAQ

1. What is Halozyme Therapeutics, Inc. (HALO) 1-year forward revenue growth estimate?

Halozyme Therapeutics, Inc. (HALO) 1-year forward revenue growth is estimated at 18.6%.

2. What is Halozyme Therapeutics, Inc. (HALO) 1-year forward EPS growth estimate?

Halozyme Therapeutics, Inc. (HALO) 1-year forward EPS growth is estimated at 22.6%.

3. What was Halozyme Therapeutics, Inc. (HALO) last EPS, and was there a surprise?

Halozyme Therapeutics, Inc. (HALO) last reported EPS was $1.08, with a 6.8% miss.

4. What is Halozyme Therapeutics, Inc. (HALO) performance across the last 10 earnings reports?

Halozyme Therapeutics, Inc. (HALO) had 3 beats and 7 misses in its last 10 earnings reports.